Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC)

Neoplasma

Volumn 49, Issue 6, 2002, Pages 415-417

  Hungi, Y C ^a   Shiau, Y C ^b   Chang, W C ^a   Kao, C H ^a   Lin, C C ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Recurrent cervical cancer; Squamous cell carcinoma antigen (SCC); Tissue polypeptide specific antigen (TPS)

Indexed keywords

SQUAMOUS CELL CARCINOMA ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; PATIENT MONITORING; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

EID: 0036972211     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. ABBOTT SCC RIABEAD insert. ABBOTT Diagnostics Division: July 1997.
2. BONFRER JM, GROENEVELD EM, KORSE CM, VAN DALEN A, OOMEN LC, IVANYI D. Monoclonal antibody M3 used in tissue polypeptide specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18. Tumor Biol 1994; 15: 210-22.
3. FERDEGHINI M, GADDUCCI A, PRONTERA C. Determination of serum levels of different cytokeratins in patients with uterine malignancies. Anticancer Res 1994; 14: 1393-1397.
4. GIAT M, ROAGNA R, PONZONE R, BIGLIA N, SGRO L, PERONA M, SISMONDI P. TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients. Anticancer Res 1996; 16: 875-881.
5. GITSCH G, KAINZ C, JOURA E, FROHLICH B, BIEGLMAYR C, TATRA G. Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer. Anticancer Res 1992; 12: 1247-1249.
6. Ho YJ, HSIEH JF, TASI SC, LEE JK, KAO CH. Tissue polypeptide antigen and squamous cell antigen for early prediction of recurrence in lung squamous cell carcinoma. Lung 2000; 178: 75-80.
7. HOBARTH K, HALLAS A, KRAMER G, AULITZKY W, GOMAHR A, STEINER G, MARBERGER M. Tissue polypeptide-specific antigen in renal cell carcinoma. Eur Urol 1996; 30: 89-95.
8. HOCKEL M, SCLENGER K, HAMM H, KNAPSTEIN PG, HOHENFELLNER R, ROSLER HP. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer 1996; 77: 1918-1933.
9. MARUO T, SHIBATA K, KIMURA A. Tumor-associated in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization. Cancer 1985; 56: 302-308.
10. NGAN HY, CHENG GT, YEUNG WS. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix. Gynecol Oncology 1994; 52: 63-68.
11. O'HANLON DM, KERIN MJ, O'BOYLE C, GRIMES H, GIVEN HF. Tissue polypeptide specific antigen (TPS) in breast canceran initial evaluation. Eur J Surg Oncol 1996; 22: 38-41.
12. Rose PG, BAKER S, FOURNIER L. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence. Amer J Obstet Gynecol 1993; 168: 942-946.
13. SABBATINI S, MONTI M, FINI A. Tissue polypeptide antigen (TPA) modifications in hepatic cirrhosis, aggressive chronic hepatitis, persistent chronic hepatitis, and in minimal pathology. Int J Biol Markers 1988; 3: 127-128.
14. SUN SS, HSIEH JF, TSAI SC, Ho YJ, KAO CH. Tissue polypetide-specific antigen and carcinoembrynic antigen for early prediction of recurrence in lung adenocarcinoma. Am J Clin Oncol 2000; 23: 605-608.
15. TARLE M, KOVACIC K, KASTELAN M. Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors. Anticancer Res 1993; 13: 215-218.
16. TEMPFER C, HEFLER L, HAEUSLER G, REINTHALLER A, KOELBL H, ZEISLER H, KAINZ C. Tissue polypeptide specific antigen in the follow-up of ovarian and cervical cancer patients. Int J Cancer 1998; 79: 241-244.
17. The working group on tumor marker criteria. Tumor Biol 1990; 11: 287-288.